MedPath

Regabin 75

Brand Name: Regabin 75

Generic Name: Pregabalin

Active
Registration Number

DR-XY48516

Dosage Form

Capsule

Issuance Date

December 1, 2022

Expiry Date

December 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength75 mg
PackagingAlu/Clear PVC-PVDC Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PregabalinActive
Monograph: Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform